JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2226
Ascendis Pharma A/S
ASND
$14.9B
| $9.37M | ﹤0.01% |
76,744
-14,375
| -16% | -$1.67M |
2019 Q1
15 quarters
|
|
2227
Graham Holdings Company
GHC
$4.9B
| $9.37M | ﹤0.01% |
15,504
-351
| -2% | -$214K |
2013 Q2
38 quarters
|
|
2228
Nordic American Tanker
NAT
$1.76B
| $9.36M | ﹤0.01% |
3,057,080
-1,061,550
| -26% | -$3.42M |
2015 Q1
31 quarters
|
|
2229
PUT
AB InBev
BUD
$149B
| $9.34M | ﹤0.01% |
155,600
+155,400
| +77,700% | +$8.35M |
2022 Q3
1 quarter
|
|
2230
CALL
Enphase Energy
ENPH
$4.43B
| $9.33M | ﹤0.01% |
35,200
+26,500
| +305% | +$7.71M |
2022 Q1
3 quarters
|
|
2231
CALL
Prologis
PLD
$122B
| $9.31M | ﹤0.01% |
82,600
| – | – |
2021 Q1
7 quarters
|
|
2232
Ternium
TX
$11.4B
| $9.29M | ﹤0.01% |
304,069
+22,930
| +8% | +$685K |
2015 Q4
28 quarters
|
|
2233
Grand Canyon Education
LOPE
$4.03B
| $9.27M | ﹤0.01% |
87,710
-19,103
| -18% | -$1.91M |
2015 Q4
28 quarters
|
|
2234
BlackRock Intermediate Muni Income Bond ETF
INMU
$656M
| $9.26M | ﹤0.01% |
+400,490
| New | +$9.23M |
2022 Q4
0 quarters
|
|
2235
Huntsman Corp
HUN
$1.52B
| $9.26M | ﹤0.01% |
336,912
+8,400
| +3% | +$229K |
2013 Q2
38 quarters
|
|
|
EVRI
2236
DELISTED
Everi Holdings
EVRI
| $9.25M | ﹤0.01% |
644,444
+71,034
| +12% | +$1.18M |
2017 Q1
23 quarters
|
|
2237
Fidelity MSCI Information Technology Index ETF
FTEC
$22.9B
| $9.24M | ﹤0.01% |
97,762
+95,908
| +5,173% | +$9.26M |
2015 Q4
28 quarters
|
|
2238
CALL
Wayfair
W
$14.8B
| $9.24M | ﹤0.01% |
280,800
+6,500
| +2% | +$227K |
2020 Q4
8 quarters
|
|
2239
Nu Skin
NUS
$227M
| $9.21M | ﹤0.01% |
218,461
+31,924
| +17% | +$1.23M |
2013 Q2
38 quarters
|
|
|
TSVT
2240
DELISTED
2seventy bio
TSVT
| $9.21M | ﹤0.01% |
982,534
+58,292
| +6% | +$822K |
2021 Q4
4 quarters
|
|
2241
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.19B
| $9.18M | ﹤0.01% |
66,461
+2,283
| +4% | +$313K |
2015 Q4
28 quarters
|
|
2242
Erie Indemnity
ERIE
$11.5B
| $9.18M | ﹤0.01% |
36,916
-56,272
| -60% | -$14.5M |
2015 Q4
28 quarters
|
|
|
PINC
2243
DELISTED
Premier
PINC
| $9.15M | ﹤0.01% |
261,629
+5,585
| +2% | +$186K |
2013 Q4
36 quarters
|
|
2244
Veracyte
VCYT
$3.89B
| $9.15M | ﹤0.01% |
385,449
+61,210
| +19% | +$1.42M |
2017 Q3
21 quarters
|
|
|
BLLD
2245
DELISTED
JPMorgan Sustainable Infrastructure ETF
BLLD
| $9.15M | ﹤0.01% |
200,000
| – | – |
2022 Q3
1 quarter
|
|
2246
First Trust Capital Strength ETF
FTCS
$7.44B
| $9.13M | ﹤0.01% |
121,874
+109,937
| +921% | +$8.11M |
2019 Q2
14 quarters
|
|
2247
CALL
Vanguard Global ex-US Real Estate ETF
VNQI
$3.24B
| $9.13M | ﹤0.01% |
234,100
+106,000
| +83% | +$4.23M |
2022 Q1
3 quarters
|
|
2248
BioCryst Pharmaceuticals
BCRX
$2.05B
| $9.12M | ﹤0.01% |
794,537
+20,334
| +3% | +$254K |
2017 Q4
20 quarters
|
|
2249
CALL
Visa
V
$693B
| $9.12M | ﹤0.01% |
43,900
+29,000
| +195% | +$5.85M |
2020 Q2
10 quarters
|
|
2250
PUT
Madrigal Pharmaceuticals
MDGL
$11.4B
| $9.11M | ﹤0.01% |
31,400
-56,700
| -64% | -$5.55M |
2022 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.